Effectiveness of a Smartphone App for Adolescent Obesity Management

Children's University Hospital, Ireland126 enrolled

Overview

Though face-to-face treatment of childhood obesity can be effective, it is time consuming and costly. This study will test whether treatment can be delivered via an Android app and whether such treatment reduces obesity.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

126

Conditions

Obesity Impaired Health Psychosocial Problem Physical Activity General Nutrition Disorder

Interventions

W82GOBEHAVIORAL

MDT delivered obesity intervention integrating behavioural change methods in order to reduce obesity; improve nutrition; increase physical activity; improve sleep; reduce sedentarism and increase self-esteem

smartphone applicationDEVICE

Behavior change smartphone application for adolescents aiming to reduce obesity

Eligibility

Sex: ALLMin age: 12 YearsMax age: 17 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * child aged between 12.0 and 17.0 years, * child BMI =/\> 98th percentile, * first language is English (or fluent in English) * parent/s willing to participate in the programme with their child * completion of written informed consent and/or assent prior to any study-specific procedures Exclusion Criteria: * severe intellectual difficulties, * obesity secondary to genetic condition, * limitations to engaging in physical activity * use of medication known to effect body weight; * limitations to using a smartphone device * known family issues that would affect general compliance and attendance at follow-up visits.

Locations (2)

Temple Street Children's University Hospital

Dublin, Ireland

Temple Street Children's University Hospital

Dublin, Ireland

Outcomes

Primary Outcomes

BMI Z score

Z score calculated using LMS growth software

Time frame: 12 months

Secondary Outcomes

Body Fat Mass

Measured using Tanita Bioelectric impedance analyser

Time frame: 12 months

Physical activity

Measured using Geneactive acclerometery

Time frame: 12 months

Laboratory tests

Lipids; glucose; insulin; HbA1C; liver function

Time frame: 12 months

Psychosocial health

Measured using the Child Behaviour Check list

Time frame: 12 months

Safety

Adverse effects will be monitored throughout the study and a full report at 12 months will be given.

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.